Choose your target and we’ll help you get a bull’s-eye.
Implement a fully automated PCR detection platform at any scale
Expand pathogen PCR testing infrastructure to support mass testing. Biosearch Technologies’ offers an automated purification and amplification workflow, which has been issued EUA from the FDA as well as received CE-IVD marking for SARS-CoV-2 detection. This system can run up to 35,000 patient samples per day on a single platform. In need of a mass testing platform? Our ultra-high-throughput PCR testing system is capable of processing up to 150,000 tests per day on a single system.
Prepare samples that maximise downstream success
PCR testing looks for the presence of nucleic acid sequences specific to the pathogen(s) of interest, such as SARS-CoV-2. Depending on your sensitivity requirements, the nucleic acid may be isolated from the sample via crude extraction or high-quality purification. Biosearch Technologies' oKtopure™ automated high-throughput extraction system and SARS-CoV-2 qualified sbeadex™ Pathogen Nucleic Acid Purification Kit is a scalable solution for recovering 100% of RNA.
Automate nucleic acid extraction at high-throughput with oKtopure.
Detect the presence of pathogens
Following extraction, probes and primers, enzymes, and other chemistries are added to the extracted nucleic acid to determine whether the target pathogen(s) are present in the sample. Biosearch Technologies’ offers a comprehensive catalogue of off-the-shelf kits for use in PCR-based pathogen detection as well as high-quality individual assay components to support diagnostic assay developers and manufacturers.
RapiDxFire qPCR 5X Master Mix GF is lyo-compatible with a glycerol-free, triton-free formulation that enables increased sensitivity. 48-hour reaction benchtop stability that’s perfect for automated or point-of-care workflows.
Mutations within a virus’ genome may influence viral characteristics such as transmissibility, immune escape and more. An RT-PCR-based assay can rapidly determine whether that viral sample contains the wild type or mutation, as long as that genome has already been sequenced through methods like whole genome sequencing.